183 related articles for article (PubMed ID: 17546575)
21. The association between patient satisfaction and quality of life in Chinese lung and liver cancer patients.
Wong WS; Fielding R
Med Care; 2008 Mar; 46(3):293-302. PubMed ID: 18388844
[TBL] [Abstract][Full Text] [Related]
22. Predictors of skin-related quality of life after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma.
Chen T; Bertenthal D; Sahay A; Sen S; Chren MM
Arch Dermatol; 2007 Nov; 143(11):1386-92. PubMed ID: 18025362
[TBL] [Abstract][Full Text] [Related]
23. Changes in quality of life over 1 year in patients with head and neck cancer.
Ronis DL; Duffy SA; Fowler KE; Khan MJ; Terrell JE
Arch Otolaryngol Head Neck Surg; 2008 Mar; 134(3):241-8. PubMed ID: 18347247
[TBL] [Abstract][Full Text] [Related]
24. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes.
Revicki D; Hays RD; Cella D; Sloan J
J Clin Epidemiol; 2008 Feb; 61(2):102-9. PubMed ID: 18177782
[TBL] [Abstract][Full Text] [Related]
25. Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life.
Elting LS; Keefe DM; Sonis ST; Garden AS; Spijkervet FK; Barasch A; Tishler RB; Canty TP; Kudrimoti MK; Vera-Llonch M;
Cancer; 2008 Nov; 113(10):2704-13. PubMed ID: 18973181
[TBL] [Abstract][Full Text] [Related]
26. Quality of life and outcomes research in head and neck cancer: a review of the state of the discipline and likely future directions.
Sayed SI; Elmiyeh B; Rhys-Evans P; Syrigos KN; Nutting CM; Harrington KJ; Kazi R
Cancer Treat Rev; 2009 Aug; 35(5):397-402. PubMed ID: 19375235
[TBL] [Abstract][Full Text] [Related]
27. Goal attainment scaling: current methodological challenges.
Tennant A
Disabil Rehabil; 2007 Oct 30-Nov 15; 29(20-21):1583-8. PubMed ID: 17882728
[TBL] [Abstract][Full Text] [Related]
28. [Quality of life among patients with advanced prostate cancer: a survey using functional assessment of cancer therapy-prostate in China].
Zhang K; Gong K; Zhou LQ; Na YQ
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(10):665-8. PubMed ID: 18642765
[TBL] [Abstract][Full Text] [Related]
29. Symptom concerns and quality of life in hepatobiliary cancers.
Sun V; Ferrell B; Juarez G; Wagman LD; Yen Y; Chung V
Oncol Nurs Forum; 2008 May; 35(3):E45-52. PubMed ID: 18467279
[TBL] [Abstract][Full Text] [Related]
30. Differences in what quality-of-life instruments measure.
Ferrans CE
J Natl Cancer Inst Monogr; 2007; (37):22-6. PubMed ID: 17951227
[TBL] [Abstract][Full Text] [Related]
31. The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials.
Pope JE; Khanna D; Norrie D; Ouimet JM
J Rheumatol; 2009 Feb; 36(2):254-9. PubMed ID: 19132791
[TBL] [Abstract][Full Text] [Related]
32. Quality of life correlates after surgery for laryngeal carcinoma.
Bindewald J; Oeken J; Wollbrueck D; Wulke C; Dietz A; Herrmann E; Schwarz R; Singer S
Laryngoscope; 2007 Oct; 117(10):1770-6. PubMed ID: 17906497
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with health-related quality-of-life in breast cancer survivors: influence of the type of surgery.
Ohsumi S; Shimozuma K; Morita S; Hara F; Takabatake D; Takashima S; Taira N; Aogi K; Takashima S
Jpn J Clin Oncol; 2009 Aug; 39(8):491-6. PubMed ID: 19520689
[TBL] [Abstract][Full Text] [Related]
34. Development and validation of the functional assessment of cancer therapy nasopharyngeal cancer subscale.
Tong MC; Lo PS; Wong KH; Yeung RM; van Hasselt CA; Eremenco S; Cella D
Head Neck; 2009 Jun; 31(6):738-47. PubMed ID: 19260135
[TBL] [Abstract][Full Text] [Related]
35. A point of minimal important difference (MID): a critique of terminology and methods.
King MT
Expert Rev Pharmacoecon Outcomes Res; 2011 Apr; 11(2):171-84. PubMed ID: 21476819
[TBL] [Abstract][Full Text] [Related]
36. Ambulatory cancer and US general population reference values and cutoff scores for the functional assessment of cancer therapy.
Pearman T; Yanez B; Peipert J; Wortman K; Beaumont J; Cella D
Cancer; 2014 Sep; 120(18):2902-9. PubMed ID: 24853866
[TBL] [Abstract][Full Text] [Related]
37. Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders.
Tubach F; Ravaud P; Beaton D; Boers M; Bombardier C; Felson DT; van der Heijde D; Wells G; Dougados M
J Rheumatol; 2007 May; 34(5):1188-93. PubMed ID: 17477485
[TBL] [Abstract][Full Text] [Related]
38. Interpreting oral health-related quality of life data.
Tsakos G; Allen PF; Steele JG; Locker D
Community Dent Oral Epidemiol; 2012 Jun; 40(3):193-200. PubMed ID: 22074311
[TBL] [Abstract][Full Text] [Related]
39. Quality of life and utility in irradiated laryngeal cancer patients.
Ringash J; Redelmeier DA; O'Sullivan B; Bezjak A
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):875-81. PubMed ID: 10863055
[TBL] [Abstract][Full Text] [Related]
40. Special issues for building computerized-adaptive tests for measuring patient-reported outcomes: the National Institute of Health's investment in new technology.
Reeve BB
Med Care; 2006 Nov; 44(11 Suppl 3):S198-204. PubMed ID: 17060828
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
